Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus that causes infe
ctious mononucleosis and is etiologically associated with malignancies of m
ultiple origins. EBV enters cells through a cascade of interactions between
its envelope glycoprotein gp350 and the gp42-gH-gL complex with cellular r
eceptors, Membrane fusion is catalyzed by the binding of gp42, a member of
the C type lectin family, to HLA class II molecule HLA-DR, -DP, or -DQ. Her
e we demonstrate that only a subset of HLA-DQ alleles mediates EBV entry, i
ndicating that individuals expressing these alleles may offer unique sites
for EBV infection and subsequent sequelae, Additionally, the specific site
within HLA-DQ determined to be essential for EBV entry is homologous to a s
ite within MHC class I shown by structural studies to bind to the C type-le
ctin-like natural killer receptor, providing insight into the biochemical n
ature of the gp42-HLA class II interaction.